Deucravacitinib in active PsA

An adult with active psoriatic arthritis, high-sensitivity C-reactive protein concentration ≥3 mg/L, and a PsA-related hand or foot erosion on radiograph is naïve to biologic disease-modifying antirheumatic drugs. You are considering evidence for an oral selective tyrosine kinase 2 inhibitor.